Entity Details
| Primary name |
DAOA_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | P59103 |
| EntryName | DAOA_HUMAN |
| FullName | D-amino acid oxidase activator |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 153 |
| SequenceStatus | complete |
| DateCreated | 2002-11-25 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Golgi apparatus |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR027929 | D-amino acid oxidase activator | Family | Family |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 181500 | OMIM | Schizophrenia (SCZD) | A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder. Disease susceptibility may be associated with variants affecting the gene represented in this entry. |
Interactions
2 interactions